105 related articles for article (PubMed ID: 10455924)
1. Cyclophosphamide 200 mg/kg lacks ability to induce pluripotent stem cell engraftment in mice.
Yoshikawa M; Tomita Y; Uchida T; Zhang QW; Shimizu I; Nomoto K
Transplant Proc; 1999 Aug; 31(5):1939. PubMed ID: 10455924
[No Abstract] [Full Text] [Related]
2. Inability of cyclophosphamide-induced tolerance to permit engraftment of pluripotent stem cells contained in a moderate number of syngeneic bone marrow cells.
Yoshikawa M; Tomita Y; Uchida T; Zhang QW; Nomoto K
Immunobiology; 2000 Apr; 201(5):552-67. PubMed ID: 10834313
[TBL] [Abstract][Full Text] [Related]
3. Platelets--cyclophosphamide-induced immunological tolerance to skin allografts in mice.
Schanzer H; Severin C; Taub RN
Transplantation; 1974 Apr; 17(4):431-5. PubMed ID: 4595928
[No Abstract] [Full Text] [Related]
4. A nonlethal conditioning approach to achieve engraftment of xenogeneic rat bone marrow in mice and to induce donor-specific tolerance.
Neipp M; Exner BG; Ildstad ST
Transplantation; 1998 Oct; 66(8):969-75. PubMed ID: 9808477
[TBL] [Abstract][Full Text] [Related]
5. Lack of pluripotent stem cell engraftment in cyclophosphamide-induced tolerance.
Yoshikawa M; Tomita Y; Uchida T; Zhang QW; Nomoto K
Transplant Proc; 1999; 31(1-2):898-9. PubMed ID: 10083396
[No Abstract] [Full Text] [Related]
6. The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice.
Mayumi H; Good RA
Transplant Proc; 1988 Feb; 20(1 Suppl 1):139-41. PubMed ID: 2894728
[No Abstract] [Full Text] [Related]
7. Cyclophosphamide-induced tolerance in kidney transplantation avoids long-term immunosuppressive therapy.
Takeuchi A; Kato K; Akashi K; Eto M
Int J Urol; 2018 Feb; 25(2):112-120. PubMed ID: 29105189
[TBL] [Abstract][Full Text] [Related]
8. Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia.
Guo Z; Gao HY; Zhang TY; Liu XD; Yang K; Lou JX; He XP; Zhang Y; Chen P; Chen HR
Int J Hematol; 2016 Dec; 104(6):720-728. PubMed ID: 27709450
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the immunosuppressive effects of 6-mercaptopurine, azathioprine, cyclophosphamide and 036.5122 (Asta) on primary and secondary immune reactions in the mouse].
Botzenhardt U; Lemmel EM
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1806-8. PubMed ID: 1030111
[No Abstract] [Full Text] [Related]
10. Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC-mismatched barriers by the additional myelosuppressive treatments in mice primed with allogeneic spleen cells followed by cyclophosphamide.
Tomita Y; Yoshikawa M; Zhang QW; Shimizu I; Okano S; Iwai T; Yasui H; Nomoto K
J Immunol; 2000 Jul; 165(1):34-41. PubMed ID: 10861032
[TBL] [Abstract][Full Text] [Related]
11. Growth of human hematopoietic cells in immunodeficient mice conditioned with cyclophosphamide and busulfan.
Basch RS; Quito FL; Beh J; Hirst JA
Stem Cells; 1997; 15(4):314-23. PubMed ID: 9253116
[TBL] [Abstract][Full Text] [Related]
12. [Changes of immunologically-mediated resistance factors after low-intensity longitudinal immunosuppressive effect].
Mamedov RM; Gamidova NA
Georgian Med News; 2009 Jan; (166):98-101. PubMed ID: 19202231
[TBL] [Abstract][Full Text] [Related]
13. Immune tolerance induced by donor antigen and cyclophosphamide in rat fetal small bowel transplantation.
Nakao M; Taguchi T; Ogita K; Nishimoto Y; Suita S
Fukuoka Igaku Zasshi; 2005 Feb; 96(2):49-57. PubMed ID: 15852663
[TBL] [Abstract][Full Text] [Related]
14. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation.
Tomita Y; Shimizu I; Iwai T; Zhang QW; Okano S; Kajiwara T; Onzuka T; Tominaga R
Scand J Immunol; 2006 Oct; 64(4):392-7. PubMed ID: 16970680
[TBL] [Abstract][Full Text] [Related]
15. The nature of drug-induced B cell tolerance.
Howard JG; Shand FL
Immunol Rev; 1979; 43():42-68. PubMed ID: 83289
[No Abstract] [Full Text] [Related]
16. Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.
Ballester OF; Agaliotis DP; Hiemenz JW; Janssen WE; Fields KK; Zorksy PE; Goldstein SC; Perkins JB; Elfenbein GJ
Bone Marrow Transplant; 1996 Jul; 18(1):9-14. PubMed ID: 8831989
[TBL] [Abstract][Full Text] [Related]
17. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive action of cyclophosphamide in mice: contribution of some factors to determination of strain differences.
Pukhalsky AL; Toptygina AP; Viktorov VV
Int J Immunopharmacol; 1993 May; 15(4):509-14. PubMed ID: 8365825
[TBL] [Abstract][Full Text] [Related]
19. The use of polyanions to break immunological tolerance.
Diamantstein T; Wagner B
Nat New Biol; 1973 Jan; 241(108):117. PubMed ID: 4512452
[No Abstract] [Full Text] [Related]
20. [Effect of temporary cyclophosphamide treatment upon allogenic rat parabioses].
Thiede A; Müller-Ruchholtz W
Z Gesamte Exp Med Einschl Exp Chir; 1969 Dec; 151(4):321-30. PubMed ID: 4394036
[No Abstract] [Full Text] [Related]
[Next] [New Search]
